WallStreetZenWallStreetZen

NASDAQ: LIMN
Liminatus Pharma Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Liminatus Pharma earnings were -$10.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest LIMN earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$8.2M, up 348% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LIMN reported annual earnings of -$10.2M, with 187.8% growth.

LIMN earnings history

Current Revenue
$0.0
Current Earnings
-$10.2M
Current Profit Margin
0%

LIMN Return on Equity

Insufficient data to display

LIMN Return on Assets

Current Company
-412.8%
Current Industry
-9.6%
LIMN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LIMN announces earnings.

LIMN Return on Capital Employed

Current Company
102.1%
Current Industry
-3.7%
LIMN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LIMN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LIMN-$9.99M-$10.21MN/A-$0.43
DRMA-$7.56M-$7.56MN/A-$8.16
CDIO-$6.09M-$6.50MN/A-$3.71
GOVX-$21.40M-$21.46MN/A-$22.40
CLGN-$10.58M-$11.49MN/A-$0.94
View Top Biotech Stocks

Liminatus Pharma Earnings Reports & History FAQ

What were Liminatus Pharma's earnings last quarter?

Liminatus Pharma (NASDAQ: LIMN) reported Q4 2025 earnings per share (EPS) of -$0.34, up 3,300% year over year. Total LIMN earnings for the quarter were -$8.17 million. In the same quarter last year, Liminatus Pharma's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Liminatus Pharma stock.

Is Liminatus Pharma profitable or losing money?

As of the last Liminatus Pharma earnings report, Liminatus Pharma is currently losing money. Liminatus Pharma's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$10.21 million, a 187.81% increase year over year.

What was LIMN's earnings growth in the past year?

As of Liminatus Pharma's earnings date in Q2 2026, Liminatus Pharma's earnings has grown year over year. LIMN earnings in the past year totalled -$10.21 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.